Dan Thornton

Dan Thornton re-joined Chiasma as Vice President, Market Access and Patient Services in September 2019. Dan was Chiasma’s first commercial employee in 2015, where he led the effort to build a comprehensive patient services operation and secure coverage and reimbursement for the launch of the first oral treatment for acromegaly. He was previously with Flexion Therapeutics, where he served as the Vice President of Market Access for the launch of their novel treatment for knee osteoarthritis. Dan has held leadership roles in the areas of market access, government affairs, reimbursement, and pricing for Shire, Targanta Therapeutics, Therion Biologics, Biogen Idec, and Johnson & Johnson. Dan holds his M.B.A. from the Wharton School and received his B.A. in Health Policy from Duke University.